Tarsus Pharmaceuticals is a California-based biopharmaceutical firm that specializes in developing ophthalmic medicines. TP-03 is its lead product candidate that works to treat blepharitis due to Demodex mites and meibomian gland disease. Alongside this, TP-04 and TP-05 are also under development to address rosacea, Lyme disease, and malaria prophylaxis, respectively.